期刊文献+

压缩雾化吸入可必特治疗慢性阻塞性肺疾病急性加重期35例疗效观察

Combressed nebulized inhalation of combivent in the treatment of 35 cases of chronic obstructive pulmonary disease with acute exacerbation
原文传递
导出
摘要 目的 探讨压缩雾化吸入可必特对慢性阻塞性肺疾病急性加重期的疗效和不良反应.方法 将75例患者随机分为两组,对照组30例采用常规治疗,治疗组35例在常规治疗基础上加用雾化治疗,观察两组治疗效果和解除主要症状、体征的时间和住院时间.结果 治疗组住院时间和喘憋、肺部喘鸣音的持续时间均明显短于对照组(P<0.05).结论 压缩雾化吸入可必特治疗慢性阻塞性肺疾病急性加重期疗效确切,方法简便,不良反应小,值得推广. Objective To explore the effect of compressed nebulized inhalation combivent on chronic obstructive pulmonary disease with acute exacerbation. Mehods Seventy-five patients were randomly divided into two groups,the control group(30 cases) with conventional treatment, the treatment group (35 cases) on the basis of conventional therapy plus treatment with the spray were observed lifting of the main symptoms and signs of the time and hospital stay.Results The treatment group hospitalization time and asthmatic lungs duration of wheezing were significantly shorter than the control group (P<0.01). Conclusions Compression combivent aerosol inhalation treatment of chronic obstructive pulmonary disease with acute exacerbation is simple, side effects are little and are worth promoting.
作者 申茹
出处 《中国实用医刊》 2010年第16期43-44,共2页 Chinese Journal of Practical Medicine
关键词 慢性阻塞性肺疾病急性加重期 沙丁胺醇 异丙托溴胺 压缩雾化 可必特 Chronic obstructive pulmonary disease with acute exacerbation Salbutamol Ipratropine Compressed-nebulized-inhalation Combivent
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部